Lv2
200 积分 2023-04-18 加入
Prodrug Strategy to Address Impaired Oral Absorption of a Weakly Basic TYK2 Inhibitor Caused by a Gastric Acid-Reducing Agent
4小时前
已完结
Advancements in NMDA Receptor-Targeted Antidepressants: From d-Cycloserine Discovery to Preclinical Efficacy of Lu AF90103
4小时前
已完结
A key to unlock ubiquitin ligase function
16小时前
已完结
Recent insights of PROTAC developments in inflammation-mediated and autoimmune targets: a critical review
1天前
已完结
Discovery and In Vivo Efficacy of AZ-PRMT5i-1, a Novel PRMT5 Inhibitor with High MTA Cooperativity
1天前
已完结
Recent Progress and Prospects of Small Molecules for NLRP3 Inflammasome Inhibition
2天前
已完结
Attenuation of NLRP3 Inflammasome Activation by Indirubin-Derived PROTAC Targeting HDAC6
2天前
已完结
Discovery of Potent, Orally Bioavailable, Tricyclic NLRP3 Inhibitors
2天前
已完结
Discovery of novel EGFR-PROTACs capable of degradation of multiple EGFR-mutated proteins
3天前
已完结
Discovery of autophagy-tethering compounds as potent NLRP3 degraders for IBD Immunotherapy
6天前
已完结
皖公网安备34019202002308
